(Q40770884)

23 September 2017

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy (English)

1 reference

23 September 2017

1 reference

1 reference

Ramachandra M

1

1 reference

23 September 2017

Rahman A

2

1 reference

23 September 2017

Zou A

3

1 reference

23 September 2017

Vaillancourt M

4

1 reference

23 September 2017

Howe JA

5

1 reference

23 September 2017

Antelman D

6

1 reference

23 September 2017

Sugarman B

7

1 reference

23 September 2017

Demers GW

8

1 reference

23 September 2017

Engler H

9

1 reference

23 September 2017

Johnson D

10

1 reference

23 September 2017

Shabram P

11

1 reference

23 September 2017

1 November 2001

1 reference

23 September 2017

1 reference

23 September 2017

19

1 reference

23 September 2017

1035-1041

1 reference

23 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt1101-1035

23 September 2017

0 references

cites work

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Replicating viruses as selective cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Binding and modulation of p53 by p300/CBP coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

A transcriptionally active DNA-binding site for human p53 protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

An adenovirus type 5 early gene function regulates expression of other early viral genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Retinoblastoma protein monoclonal antibodies with novel characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region

1 reference

https://api.crossref.org/works/10.1038%2FNBT1101-1035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NBT1101-1035

1 reference

23 September 2017

1 reference